(Q39648378)

13 September 2017

title

Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era (English)

1 reference

https://api.crossref.org/works/10.3109/10428194.2010.516039

27 July 2024

1 reference

diffuse large B-cell lymphoma

1 reference

1 reference

Mariano Provencio

1

1 reference

13 September 2017

Paloma Martín

2

1 reference

13 September 2017

Vanesa García

3

1 reference

13 September 2017

Antonio Candia

4

1 reference

13 September 2017

Carmen Bellas

6

1 reference

13 September 2017

Antonio C. Sánchez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20919853

27 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20919853

27 July 2024

publication date

4 October 2010

1 reference

full work available at URL

13 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2010.516039

1 reference

https://api.crossref.org/works/10.3109/10428194.2010.516039

27 July 2024

1 reference

13 September 2017

volume

51

1 reference

13 September 2017

issue

11

1 reference

13 September 2017

page(s)

2021-2030

1 reference

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Caspase-3 activation in systemic anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Mechanisms of caspase activation and inhibition during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

DMNQ-S17 inhibits constitutive NF-kappaB activation leading to induction of apoptosis through the activation of caspase-3 in human myeloid leukemia U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Caspase-independent killing of Burkitt lymphoma cell lines by rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

The involvement of mitochondria and the caspase-9 activation pathway in rituximab-induced apoptosis in FL cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.516039

The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma

21 January 2018

17

1 reference

https://api.crossref.org/works/10.3109/10428194.2010.516039

Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas

27 July 2024

18

1 reference

https://api.crossref.org/works/10.3109/10428194.2010.516039

27 July 2024

Identifiers

1 reference

13 September 2017

1 reference